Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Ty Wright"


6 mentions found


That's a major reason why we took a stake in the company in April 2022 and a key growth area for the health insurance industry overall. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Persons: Jim Cramer, Cigna, I've, Jim, It's, That's, Joe Biden, Biden, Lina Khan, Jim Cramer's, Ty Wright Organizations: Street, Humana, Express, Aetna, CVS Health, Cigna, Federal Trade Commission, Justice Department, FTC, CNBC, Bloomberg, Getty Locations: U.S, Louisville , Kentucky
Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Not only did second-quarter numbers top expectations, but management offered assuring commentary on the worrisome medical-cost trends that torpedoed its stock price in mid-June . That one-two punch explains the more-than-5% jump in Humana shares, pushing the stock to its highest levels since June 14. Outlook Humana raised its outlook for 2023 individual Medicare Advantage membership growth by 50,000 to roughly 825,000 members, representing an 18% increase compared with enrollment levels at the end of 2022. Capital allocation Humana CFO Susan Diamond said the company has capitalized on the "recent dislocation" in its stock price — i.e.
Persons: MLR —, Wall, Bruce Broussard, , Broussard, Susan Diamond, Humana, Jim Cramer's, Jim Cramer, Jim, Ty Wright Organizations: Revenue, Humana, Club, UnitedHealth, Management, Insurance, CNBC, Bloomberg, Getty Locations: Louisville , Kentucky
Adjusted revenue increased 12% year-over-year, to $25.65 billion, slightly below analysts' forecasts of $26.44 billion, according to estimates compiled by Refinitiv. Looking forward, we expect the strong membership-growth rates seen in the first quarter to drive further upside throughout 2023. The 2023 benefits expense ratio range was left unchanged, in a range of 86.3% to 87.3%, slightly above the 86.6% ratio predicted by analysts at the midpoint. Full-year operating cash flow guidance was also left unchanged, at $4.5 billion, compared with analysts' forecasts for $4.36 billion. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
We are initiating a position in Caterpillar (CAT), buying 55 shares at roughly $257.86 apiece. In addition, we are selling 50 shares of Starbucks (SBUX) at roughly $106.87 a share. SBUX 1Y mountain Starbucks (SBUX) shares 1-year performance As for Starbucks , this small trim is consistent with our strategy of taking profits following the coffeemaker's big run. (Jim Cramer's Charitable Trust is long CAT, SBUX. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Full-year 2022 guidance was in-line with the updated outlook provided at the health insurer's September investor day. But we did get some commentary looking ahead to 2023 that pushed the stock 2% higher in Wednesday's down market. The Q3 benefits expense ratio in the quarter was 86.5%, down (again, lower is better), down from 88.1% in the year ago period. The Q3 benefits expense ratio in the quarter saw significant improvement, falling to 78.7% from 86.4% last year. Outlook Management affirmed their adjusted full-year 2022 EPS outlook of approximately $25 per share, representing 21% annual growth versus 2021 an in-line with expectations.
Humana increased its adjusted earnings per share guidance for full-year 2022 to about $25, up 25 cents from its previous estimate. We knew there was a possibility that Humana would raise its target, which could cause the stock to rally. This can help boost Medicare Advantage revenue and ultimately help Humana get on the path of $37 per share. We are confident that the Medicare Advantage business will continue to grow. While it's business largely comes from Medicare Advantage plans sold to retail customers, we should point out that Humana's services expand the addressable health care market.
Total: 6